You are here

UK

Moderna cuts COVID-19 vaccine deliveries to Canada, U.K. amid European supply struggles

Moderna cuts COVID-19 vaccine deliveries to Canada, U.K. amid European supply struggles

Fierce Pharma

Moderna Therapeutics

Flag link:

MHRA kicks off new accelerated drug approval pathway with ‘innovation passports’

MHRA kicks off new accelerated drug approval pathway with ‘innovation passports’

Endpoints

accelerated approvals

Flag link:

GlaxoSmithKline, Novavax team up on COVID vaccine production in U.K., helping reduce dependence on AZ shot

GlaxoSmithKline, Novavax team up on COVID vaccine production in U.K., helping reduce dependence on AZ shot

Fierce Pharma

drug manufacturing

Flag link:

The Brexit deal; shot in the arm or kick in the teeth for the pharma sector?

The Brexit deal; shot in the arm or kick in the teeth for the pharma sector?

Pharmaforum

Flag link:

GSK kick-starts phase 3 Medicago-partnered COVID vaccine test

GSK kick-starts phase 3 Medicago-partnered COVID vaccine test

Fierce Biotech

Flag link:

AbbVie sells biologics plant to Pharmaron, fueling the China company's cell and gene therapy ambitions

AbbVie sells biologics plant to Pharmaron, fueling the China company's cell and gene therapy ambitions

Fierce Pharma

drug manufacturing

Flag link:

Fledgling CDMO Lakes BioScience blueprints $490M antibody factory at ex-GlaxoSmithKline site

Fledgling CDMO Lakes BioScience blueprints $490M antibody factory at ex-GlaxoSmithKline site

Fierce Pharma

Lake BioScience

drug manufacturing

Flag link:

In first for the world, Britain OKs challenge trial exposing volunteers to COVID-19

In first for the world, Britain OKs challenge trial exposing volunteers to COVID-19

Reuters

challenge trials

clinical trials

Flag link:

10 biotechs become 1: Centessa launches with $250M to prove unorthodox R&D model

10 biotechs become 1: Centessa launches with $250M to prove unorthodox R&D model

BioPharma Dive

Centessa Pharmaceuticals

Flag link:

Disgraced biotech investor Woodford plans revival amid UK life science boom

Disgraced biotech investor Woodford plans revival amid UK life science boom

Pharmaforum

Flag link:

What does Brexit mean for biopharma companies?

What does Brexit mean for biopharma companies?

Biopharma Reporter

Flag link:

Novavax starts rolling reviews for COVID-19 vaccine

Novavax starts rolling reviews for COVID-19 vaccine

Biopharma Reporter

Flag link:

Novavax Initiates Rolling Review for Vaccine & Other COVID News

Novavax Initiates Rolling Review for Vaccine & Other COVID News

BioSpace

Flag link:

Novavax CEO: UK data should be used for quicker U.S. COVID-19 vaccine rollout

Novavax CEO: UK data should be used for quicker U.S. COVID-19 vaccine rollout

Yahoo

clinical trials

Flag link:

AstraZeneca defends slow supplies to the EU, but says it ordered 3 months later than the UK

AstraZeneca defends slow supplies to the EU, but says it ordered 3 months later than the UK

CNBC

Flag link:

Pfizer-BioNTech Covid-19 vaccine works just as well against variant first detected in U.K., study indicates

Pfizer-BioNTech Covid-19 vaccine works just as well against variant first detected in U.K., study indicates

Stat

B.1.1.7 variant

Flag link:

Needle-free COVID-19 vaccine COVI-VAC enters Phase 1 trials

Needle-free COVID-19 vaccine COVI-VAC enters Phase 1 trials

Biopharma Reporter

intranasal vaccines

clinical trials

Flag link:

Moderna's COVID-19 vaccine becomes third to be authorized by U.K. regulator

Moderna's COVID-19 vaccine becomes third to be authorized by U.K. regulator

Marketwatch

Moderna Therapeutics

Flag link:

Virologists Voice Growing Concern Over South African COVID-19 Variant

Virologists Voice Growing Concern Over South African COVID-19 Variant

BioSpace

Flag link:

FDA and doctors warn against extending COVID-19 vaccine dose gap

FDA and doctors warn against extending COVID-19 vaccine dose gap

Pharmaforum

Flag link:

Pages